Dental management of scleroderma patients using pentoxifylline plus vitamin E with and without TheraBite® to reduce trismus: Two case reports and brief review of literature
- PMID: 32128166
- PMCID: PMC7044382
- DOI: 10.1002/ccr3.2572
Dental management of scleroderma patients using pentoxifylline plus vitamin E with and without TheraBite® to reduce trismus: Two case reports and brief review of literature
Abstract
To provide evidence supporting the off label use of pentoxifylline and vitamin E especially by dentists with TheraByte to reduce trismus in scleroderma patients.
Keywords: Thera Bite®; VitE; pentoxifylline; scleroderma; trismus.
© 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
There were no conflicts of interest or external funding sources to disclose.
References
-
- deSouza RBC, Macedo AR, Kuruma KA, Macedo PA. Pentoxifylline in association with vitamin E reduces cutaneous fibrosis in systemic sclerosis. Clin Rheumatol. 2009;28:1207‐1212. - PubMed
-
- Fischer DJ, Patton LL. Scleroderma: oral manifestations and treatment challenges. Spec Care Dent. 2000;20:240‐244. - PubMed
-
- Mayes MD, Lacey JV, Beebe‐Dimmer J, Gillespie BW. Prevalence, incidence, survival and disease characteristics of systemic sclerosis in a large US population. Arthritis & Rheum. 2003;48:2246‐2255. - PubMed
-
- Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol. 2011;40:78‐83. - PubMed
-
- Schumacher HR Jr, Kippel JH, Robinson DR, eds. Systemic sclerosis and localized scleroderma In: Primer on Rheumatic Diseases (9th edn). Atlanta, GA: Arthritis Foundation; 1988;111‐117.
Publication types
LinkOut - more resources
Full Text Sources
